BioNexus Gene Lab Corp. Income Taxes Paid
BioNexus Gene Lab Corp. (BGLC) reported Income Taxes Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-08-14
- BioNexus Gene Lab Corp. income taxes paid for the quarter ending 2021-03-31 was -$36.44K.
- BioNexus Gene Lab Corp. income taxes paid for the quarter ending 2020-12-31 was $166.12K, a 474.88% increase year-over-year.
- BioNexus Gene Lab Corp. income taxes paid for the quarter ending 2020-09-30 was $317.00.
- BioNexus Gene Lab Corp. income taxes paid for the quarter ending 2020-06-30 was $60.28K.
- BioNexus Gene Lab Corp. income taxes paid for fiscal 2024 was $15.80K, a 59.37% decline from fiscal 2023.
- BioNexus Gene Lab Corp. income taxes paid for fiscal 2023 was $38.88K, a 19.68% decline from fiscal 2022.
- BioNexus Gene Lab Corp. income taxes paid for fiscal 2022 was $48.41K, a 81.70% decline from fiscal 2021.
- BioNexus Gene Lab Corp. income taxes paid for fiscal 2021 was $264.55K, a 55.94% increase from fiscal 2020.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 6 month as first filed | Income Taxes Paid 9 month | Income Taxes Paid 12 month | Income Taxes Paid 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | |||||
| 2025-06-30 | $12.51K 10-Q · filed 2026-08-14 | |||||
| 2024-12-31 | $15.80K 10-K · filed 2025-04-15 | |||||
| 2023-12-31 | $38.88K 10-K · filed 2025-04-15 | |||||
| 2022-12-31 | $48.41K 10-K · filed 2024-04-16 | |||||
| 2021-12-31 | $264.55K 10-K · filed 2023-03-31 | |||||
| 2021-03-31 | -$36.44K 10-Q · filed 2021-05-18 | $129.68K derived: sum of 2 quarters · filed 2022-04-06 | $130.00K derived: sum of 3 quarters · filed 2022-04-06 | $190.28K derived: sum of 4 quarters · filed 2022-04-06 | ||
| 2020-12-31 | $166.12K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-04-06 | $166.44K derived: sum of 2 quarters · filed 2022-04-06 | $226.72K derived: sum of 3 quarters · filed 2022-04-06 | $169.65K 10-K · filed 2022-04-06 | ||
| 2020-09-30 | $317.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | $60.60K derived: sum of 2 quarters · filed 2020-11-09 | $3.53K 10-Q/A · filed 2020-11-09 | $32.43K derived: sum of 4 quarters · filed 2021-05-18 | ||
| 2020-06-30 | $60.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $3.21K 10-Q · filed 2020-08-11 | $32.11K derived: sum of 3 quarters · filed 2021-05-18 | $29.01K derived: sum of 4 quarters · filed 2021-05-18 | ||
| 2020-03-31 | -$57.07K 10-Q · filed 2021-05-18 | -$28.17K derived: sum of 2 quarters · filed 2021-05-18 | -$31.27K derived: sum of 3 quarters · filed 2021-05-18 | |||
| 2019-12-31 | $28.90K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | $25.79K derived: sum of 2 quarters · filed 2021-03-30 | $24.76K 10-K · filed 2021-03-30 | -$10.71K 10-K · filed 2020-03-31 | ||
| 2019-09-30 | -$3.10K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | -$4.14K 10-Q/A · filed 2020-11-09 | ||||
| 2019-06-30 | -$1.03K 10-Q · filed 2020-08-11 | $1.03K 10-Q · filed 2019-08-09 | ||||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |